BOSS, Christoph,BROTSCHI, Christine,GUDE, Markus,HEIDMANN, Bibia,SIFFERLEN, Thierry,VON RAUMER, Markus,WILLIAMS, Jodi T.
申请号:
HK16114201.8
公开号:
HK1225736A
申请日:
2016.12.14
申请国别(地区):
HK
年份:
2017
代理人:
摘要:
The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.